FDA Brief

Company record

Cipla Limited

1 FDA warning letter since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Cipla Limited.

Warning letters

  1. Cipla Limited

    FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.

    High risk

Recalls

ReportedClassFirmProduct and reason
Dec 10, 2025 Class II Cipla Limited
Drug
Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097…
Failed Stability Specifications: Observed OOS results: eg results for colour index